By Plenary Sessions: Irja Lutsar

The focus is entirely domestic, addressing the Estonian Medicinal Products Act, the supervisory capacity of the State Agency of Medicines, and the funding principles of the Health Insurance Fund (Tervisekassa). Specific Estonian institutions are mentioned, such as the pharmacy of the Tartu University Hospital, along with top Estonian specialists (Professor Hele Everaus).

The focus is clearly international and pan-European, concentrating on substances originating from China and the role of the European Union as a unified actor. Local or domestic issues are absent.

Insufficient data.

Insufficient data.

Insufficient data.